Johnson Matthey PLC (LON:JMAT) Insider Purchases £404.85 in Stock

Johnson Matthey PLC (LON:JMAT) insider John Walker bought 15 shares of Johnson Matthey stock in a transaction dated Wednesday, February 19th. The shares were bought at an average price of GBX 2,699 ($35.50) per share, for a total transaction of £404.85 ($532.56).

John Walker also recently made the following trade(s):

  • On Wednesday, January 15th, John Walker purchased 12 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 2,920 ($38.41) per share, with a total value of £350.40 ($460.93).

Shares of JMAT traded up GBX 66 ($0.87) on Thursday, reaching GBX 2,778 ($36.54). 631,244 shares of the company’s stock were exchanged, compared to its average volume of 691,012. The company has a current ratio of 1.54, a quick ratio of 0.90 and a debt-to-equity ratio of 59.25. The stock has a market capitalization of $5.38 billion and a P/E ratio of 13.88. The business has a 50 day moving average price of GBX 2,785.76 and a two-hundred day moving average price of GBX 2,946.58. Johnson Matthey PLC has a 12 month low of GBX 2,595 ($34.14) and a 12 month high of GBX 3,475 ($45.71).

A number of equities research analysts recently weighed in on JMAT shares. UBS Group reissued a “sell” rating on shares of Johnson Matthey in a research note on Tuesday. JPMorgan Chase & Co. downgraded shares of Johnson Matthey to an “underweight” rating and dropped their price target for the stock from GBX 3,400 ($44.73) to GBX 2,850 ($37.49) in a research note on Thursday, November 28th. Citigroup reissued a “buy” rating on shares of Johnson Matthey in a research note on Tuesday, December 3rd. Barclays dropped their price target on shares of Johnson Matthey from GBX 3,790 ($49.86) to GBX 3,330 ($43.80) and set an “equal weight” rating for the company in a research note on Wednesday, November 27th. Finally, Sanford C. Bernstein boosted their price target on shares of Johnson Matthey from GBX 4,000 ($52.62) to GBX 4,100 ($53.93) and gave the stock an “outperform” rating in a research note on Monday, January 13th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of GBX 3,481.11 ($45.79).

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Story: Closed-End Mutual Funds

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit